A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD

Completed · Phase 3 · Has a placebo group

Conditions studied: Depression, Postpartum, Depression, Post-Partum, Postpartum Depression (PPD), Post-Natal Depression, Peripartum Depression, Postnatal Depression

In brief

The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine: * If LPCN 1154A reduces depressive symptoms in subjects with severe PPD * How well LPCN 1154A is tolerated and what side effects it may cause * If LPCN 1154A reduces anxiety symptoms in subjects with severe PPD

Key facts

Study ID
NCT06979544
Run by
Lipocine Inc.
People needed
90
Starts
2025-06-16
Expected to finish
2026-02-17
Last updated by the study team
2026-02-24

Who can join

Age: 15 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.